Newsletters
Subscribe
interview
2Firsts Interviews FDA: Can Age Verification Technology Unlock Flavored Vape Approval? FDA Responds
2Firsts Interviews FDA: Can Age Verification Technology Unlock Flavored Vape Approval? FDA Responds
In response to an interview with 2Firsts, the FDA said it welcomes applications for products with age-verified technology, but emphasized that products must demonstrate compliance with "public health standards" and will be "reviewed on a case-by-case basis." The technology is a consideration for youth risk reduction, but is not an automatic guarantee of approval, especially for flavored products, and the FDA encourages companies to communicate their technological innovations.
Mar.27
Breaking Free: The Power of Constraints – Ex-BAT Exec on Innovation in NGP
Breaking Free: The Power of Constraints – Ex-BAT Exec on Innovation in NGP
Former BAT innovation executive Chris Gemmell explains how innate limitations can help product developers understand and solve problems.
Mar.13
FDA’s PMTA Shake-Up: What’s Next for the Global NGP Industry?——2Firsts Exclusive Interview with CSUR’s Dr. Andrea Patton
FDA’s PMTA Shake-Up: What’s Next for the Global NGP Industry?——2Firsts Exclusive Interview with CSUR’s Dr. Andrea Patton
As the FDA tightens NGP regulations, the U.S.—the world’s largest market—is undergoing a seismic shift, with the industry facing a potential reset.
As a leading authority on FDA’s PMTA process, CSUR brings deep expertise in regulatory science and consumer behavior analytics.
Dr. Patton discusses shifting FDA priorities, the role of behavioral science in PMTA approvals, and how businesses can balance compliance with market competitiveness amid industry restructuring.
Feb.25
Russia’s NGPs Market Faces 20% Growth Amid Regulation Challenges: An Exclusive Interview with Fedotov
Russia’s NGPs Market Faces 20% Growth Amid Regulation Challenges: An Exclusive Interview with Fedotov
Russia’s NGPs market is set for 20% growth in 2025, but regulatory pressures and a dominant illicit sector pose challenges. In a 2Firsts exclusive, Fedotov Group’s Evgeny Fedotov shares insights on PMI’s HTP dominance, ENDS shifts, and China’s growing role. Can legal brands stay ahead?
Feb.24
As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview
As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview
India supplies 85% of global nicotine, making it key to the NGP industry’s raw material chain. As regulations and consumer trends evolve, leading manufacturer Nico Orgo advocates natural nicotine over synthetic, emphasizing purity, innovation, and supply stability. Kartik Laijawala, Director at Nico Orgo, shares how the company navigates tightening regulations on synthetic nicotine and disposable vapes, leveraging its expertise to shape the industry's future.
Feb.10
How Regulation and Innovation Are Reshaping South Korea’s $11.3 Billion E-Cigarette Industry – Insights from 2Firsts Interview with Connected Korea’s Sales Manager
How Regulation and Innovation Are Reshaping South Korea’s $11.3 Billion E-Cigarette Industry – Insights from 2Firsts Interview with Connected Korea’s Sales Manager
South Korea's e-cigarette industry, valued at $11.3 billion in 2023, is undergoing significant transformation. As consumers shift to alternatives like Heated Not Burn (HNB) devices and e-cigarettes, the market faces both challenges and opportunities. In an exclusive 2Firsts interview, Sam Kim, Sales Director of Connected Korea, discusses navigating this evolving landscape, covering regulatory challenges, online retail growth, changing consumer preferences, and innovations like the “Mix-craft” de
Feb.07
2Firsts Exclusive: Cinda Securities Analyst Weighs in on Smoore’s Market Value-Linked Incentives as Company Eyes Ambitious Growth
2Firsts Exclusive: Cinda Securities Analyst Weighs in on Smoore’s Market Value-Linked Incentives as Company Eyes Ambitious Growth
Smoore has unveiled a rare equity incentive plan linked to market value, targeting executives including Chairman Chen Zhiping. This bold move aims to align leadership with the company's long-term growth ambitions and enhance investor confidence. Cinda Securities analysts Wenqiang Jiang and Chen Li discuss the strategic implications of this plan, emphasizing Smoore’s focus on expanding its HNB and vaping businesses, while also exploring new ventures in medical nd beauty sectors.
Jan.22
Scientific Solutions for Tobacco Harm Reduction: A 2Firsts Interview with JTI
Scientific Solutions for Tobacco Harm Reduction: A 2Firsts Interview with JTI
In an exclusive interview with 2Firsts, Ian Jones, Vice President of the R&D Scientific Product Assessment Center at JTI, discussed the company’s approach to advancing tobacco harm reduction (THR) and the evolving landscape of reduced-risk products (RRPs). From oral nicotine delivery systems to heated tobacco products, Jones highlighted JTI’s scientific priorities and the challenges faced by the industry.
JTI
Jan.13
ARAC Chief Research Officer on PMTAs & U.S. Regulatory Environment: Age-Gating Useful, But Scientific Evaluation Critical; Companies Must Adapt to New FDA Requirements
ARAC Chief Research Officer on PMTAs & U.S. Regulatory Environment: Age-Gating Useful, But Scientific Evaluation Critical; Companies Must Adapt to New FDA Requirements
In response to FDA's recent memo on PMTA applications for non-tobacco flavored e-cigarettes, 2Firsts spoke with Dr. Jessica Zdinak, Chief Research Officer and CEO at ARAC. She explained the challenges in the FDA review process and stressed that while age-gating technology can help, it is not a substitute for scientific evaluation. Dr. Zdinak also urged manufacturers to increase investment in scientific research to meet FDA requirements.
Nov.26
Analysis of FDA Regulatory Science Policy Memos: Age-Gating Products Prioritized, Non-Tobacco Flavors Must Demonstrate 'Incremental Benefit'
Analysis of FDA Regulatory Science Policy Memos: Age-Gating Products Prioritized, Non-Tobacco Flavors Must Demonstrate 'Incremental Benefit'
On November 21, FDA released 13 scientific policy memos regarding PMTA reviews. Insights from discussions between 2Firsts and compliance experts revealed that vape products incorporating "age-gating technology" will be prioritized for review. Additionally, FDA stated that non-tobacco flavored vapes must provide evidence of "incremental benefits" for adult smokers. Applications without randomized controlled trials or long-term study data may be classified as "fatal flaw".
Nov.22
Load more content
Most Read
1
2Firsts Interviews FDA: Can Age Verification Technology Unlock Flavored Vape Approval? FDA Responds
2
Breaking Free: The Power of Constraints – Ex-BAT Exec on Innovation in NGP
3
FDA’s PMTA Shake-Up: What’s Next for the Global NGP Industry?——2Firsts Exclusive Interview with CSUR’s Dr. Andrea Patton
4
Russia’s NGPs Market Faces 20% Growth Amid Regulation Challenges: An Exclusive Interview with Fedotov
5
Pioneering Technology For A Better Tomorrow - Global NGP Innovation & Tech Forum 2025 Successfully Held By 2First
6
Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban
7
How To Protect Minors From E-cigarettes: Interview with Director Chen Huan
8
Rising Trend: China’s Nicotine Pouch Exports Surge 500% in December 2024, Primarily Driven by the U.S. Market
9
As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview
10
How Regulation and Innovation Are Reshaping South Korea’s $11.3 Billion E-Cigarette Industry – Insights from 2Firsts Interview with Connected Korea’s Sales Manager
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
sign up
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit
https://www.2firsts.cn
English
English
中文
русский язык
español